2014
Understanding therapeutic pathways and comorbidities in psoriasis.
Gordon K, Strober B. Understanding therapeutic pathways and comorbidities in psoriasis. Seminars In Cutaneous Medicine And Surgery 2014, 33: s20-3. PMID: 24979540, DOI: 10.12788/j.sder.0067.Peer-Reviewed Original ResearchConceptsImmunologic pathwaysQuality of lifeJoint symptomsBiologic medicationsPathophysiologic pathwaysSystemic diseaseTherapeutic armamentariumInflammatory diseasesTherapeutic pathwaysPsoriasisKeratinocyte proliferationMedicationsHealth risksDiseasePathwayComorbiditiesMorbiditySymptomsArmamentariumMortality
2007
Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review
Sterry W, Strober B, Menter A, Council O. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. British Journal Of Dermatology 2007, 157: 649-655. PMID: 17627791, DOI: 10.1111/j.1365-2133.2007.08068.x.Peer-Reviewed Original ResearchConceptsMore severe psoriasisStandard of careEvidence-based literatureCardiovascular comorbiditiesImportant healthcare issueSevere psoriasisSystemic inflammationYounger patientsMetabolic syndromeRheumatoid arthritisInsulin resistanceMyocardial infarctionPsoriasisTherapeutic implicationsObesityStrong associationComorbiditiesMedical specialtiesPatientsHealthcare issuesPathophysiologyHealth risksAssociationRiskDyslipidaemia